STTR Overview ̶ Speeding Cancer Research and Improving Clinical Care
Seattle Translational Tumor Research (STTR) creates environments which enable researchers and clinicians to accelerate scientific discovery and translate it into preventions and cures for patients.
Congratulations to the winners of the 2017 STTR grants! We received many high quality proposals which spanned several exciting new technologies and precision medicine approaches.
In our Fall newsletter find out who received awards at the 2016 Oncology Recognition Day, get an update on the Oncoscape, our collaborative platform and community resource, and read clinical research updates.
We are excited to announce the expansion of STTR programing to include liquid tumor entities within STTR. Desert Horse-Grant will now focus on translational “cancer” research under one umbrella. Four new liquid and one additional solid tumor group into STTR: leukemia, lymphoma, myeloma, myelodysplastic syndromes/myeloproliferative neoplasms, and anogenital cancers.
STTR Clinical Trials Spotlight, November 2015
In this issue of the STTR newsletter, we feature a clinical trial in progress for bladder, brain, breasts, colorectal, head and neck, lung, ovarian, pancreatic, prostate and sarcoma. Also, learn more about our comprehensive online resource database for patients, caregivers, friends and family.
Read current news from STTR including how to apply for a new $1 million grant opportunity, how to find NIH and other foundation grant opportunities and plans for a new mouse model database.
STTRconnect Patient and Caregiver Cancer Resources
Need Help? New database points cancer patients to no- o rlow-cost resources including transportation, wigs, gentle yoga and summer camps for patients' kids.
STTR Newsletter, Spring 2015
The new year brings new opportunities for our scientists and the world. We were extremely encouraged by the wonderful turnout and community support at the Hutch Gala on December 6, 2014. The money raised at the gala will provide the needed support for innovative and translational research at Fred Hutch. 2015 started with the launch of two new STTR initiatives: STTRconnect and Oncoscape.
Desert Horse-Grant, director of strategic planning and operations for Solid Tumor Translational Research
STTR's Desert Horse-Grant named 'Disruptive Woman to Watch in 2015'
January 13, 2015
By Mary Engel/Fred Hutch News Service
Desert Horse-Grant, director of strategic planning and operations for Solid Tumor Translational Research (STTR) across Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance, has been named a “Disruptive Woman to Watch in 2015” by Disruptive Women in Health Care, a group that spotlights women whose achievements and ideas advance and improve health care.
Revolutionizing solid tumor treatment
Fred Hutch Quest Magazine, Winter 2013
By Deborah Bach/Fred Hutch News Service
Dr. Eric Holland is a world-renowned brain cancer researcher, a top neurosurgeon and the ideal person to lead Fred Hutch toward precise new tumor therapies.
STTR Annual Report
Inventing the Future: The People, The Programs, The Promise
A review of the past year's activities and successes.
Read more >
STTR Mid-Year Newsletter
Providing program updates, announcements of grant award recipients and more of what has been happening in Solid Tumor Translational Research.
